Related Experiment Video
Updated: Aug 9, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Duration of treatment of deep vein thrombosis: time for a new approach?
Paula G Rychlik1, Karol S Henry, Henry I Bussey
1College of Pharmacy, University of Texas at Austin, Austin, Texas, USA.
Insights
Patients with idiopathic deep vein thrombosis (DVT) may benefit from risk stratification to personalize anticoagulation therapy duration. Identifying low-risk individuals could allow for safe discontinuation of treatment, optimizing patient care.
Area of Science:
- Cardiology
- Hematology
- Vascular Medicine
Background:
- Current guidelines recommend 6-12 months of anticoagulation for idiopathic deep vein thrombosis (DVT).
- Optimal treatment duration and intensity remain subjects of debate.
- Risk stratification may allow for personalized anticoagulation withdrawal.
Purpose of the Study:
- To explore the feasibility of stratifying patients with idiopathic DVT based on recurrence risk.
- To determine if risk stratification can guide decisions on oral anticoagulation discontinuation.
Main Methods:
- Review of parameters used for risk stratification in idiopathic DVT.
- Analysis of D-dimer levels, ultrasound-confirmed thrombosis resolution, and sex as risk predictors.
Main Results:
- Idiopathic DVT patients can potentially be categorized into low and high risk groups for recurrence.
- D-dimer levels, ultrasound findings, and sex are considered risk stratification parameters.
Conclusions:
- Risk stratification may enable safe cessation of anticoagulation in low-risk idiopathic DVT patients.
- Continued anticoagulation may be warranted for high-risk individuals.
- Personalized treatment strategies can be developed based on individual risk profiles.
Abstract:
The American College of Chest Physicians Consensus Conference on Antithrombotic Therapy recommends that patients with initial idiopathic deep vein thrombosis (DVT) receive treatment for at least 6-12 months. However, controversy exists as to what treatment duration and intensity are optimal. Some investigators have suggested that it may be feasible to identify patients who are at low risk and those who are at high risk of recurrent venous thromboembolism. If patients can be stratified according to risk, then it might be safe and effective to withdraw oral anticoagulation therapy in those at low risk of recurrence and continue the therapy in those at high risk. Parameters that have been used to attempt to stratify patients with idiopathic DVT according to risk are D-dimer levels, resolution of thrombosis on ultrasound, and sex.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

